JOSEPH M LIMBER
CIK 1216023 · last filed 2026-07-14
JOSEPH M LIMBER is a corporate insider who has filed 29 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for XOMA, was dated Jul 14, 2026. Across all open-market trades the lifetime net is +$760.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $320.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$320.2K
5
29
$760.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XOMA | Director | 0 | $40.17 | $0 | $0 | 16 | 2026-07-14 |
| XOMAP | Director | 12,820 | $24.98 | $320.2K | $760.1K | 7 | 2026-05-26 |
| CombiMatrix Corp (CBMX) Delisted | Director | — | — | — | $0 | 1 | 2012-03-01 |
| Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted | Director | — | — | — | $0 | 2 | 2010-05-17 |
| PANACOS PHARMACEUTICALS, INC. (PANC) Delisted | Director | — | — | — | $0 | 3 | 2008-06-30 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | XOMA | Mixed | −39,532 | $0 | EDGAR |
| 2026-05-26 | XOMAP | Grant (A) | +3,586 | $0 | EDGAR |
| 2025-05-23 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2025-04-07 | XOMAP | Buy (P) | +30,000 | $760.1K | EDGAR |
| 2024-05-17 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2021-05-21 | XOMAP | Grant (A) | — | $0 | EDGAR |
| 2020-05-27 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | XOMA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.